Market Research Logo

Evotec SE (EVT) - Financial and Strategic SWOT Analysis Review

Evotec SE (EVT) - Financial and Strategic SWOT Analysis Review

Evotec SE (EVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Evotec SE (Evotec) is a drug discovery alliance and development partnership company. It identifies and develops small molecule drugs across various therapeutic areas such as, cancer, neurological and nephrological conditions, cardiovascular, inflammation, pain, metabolic and respiratory diseases. Evotec provides drug discovery services such as integrated assay development and screening, reagent production services, ADMET, cellular target profiling, in vitro pharmacology services, integrated CMC and proteomics services. The company has long-term discovery alliances with several leading pharmaceutical companies and also has development partnerships for product candidates in clinical and pre-clinical development stages. The company has operating facilities in Abingdon and Manchester, the UK; Gottingen and Munich, Germany, Branford ,Princeton and Watertown, the US; Verona, Italy; Basel, Switzerland; and Toulouseas well as Lyon, France. Evotec is headquartered in Hamburg, Germany.

Evotec SE Key Recent Developments

Aug 14,2019: Evotec reports first half-year 2019 results and corporate updates
Aug 01,2019: Evotec: New IMI project 'GNA Now' kicks off its Battle Against Antimicrobial Resistance
Jul 09,2019: Evotec spin-off to develop cancer drugs using DDR pathway
Jul 08,2019: Evotec and Venture Capital Consortium form 'Breakpoint Therapeutics'
Jul 05,2019: Nosopharm and Evotec to develop antibiotic drugs

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Evotec SE - Key Facts
Evotec SE - Key Employees
Evotec SE - Key Employee Biographies
Evotec SE - Major Products and Services
Evotec SE - History
Evotec SE - Company Statement
Evotec SE - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Evotec SE - Business Description
Business Segment: EVT Execute Segment
Overview
Performance
Business Segment: EVT Innovate Segment
Overview
Performance
Business Segment: Transition
Performance
Geographical Segment: France
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Others
Performance
Geographical Segment: United Kingdom
Performance
Geographical Segment: USA
Performance
Evotec SE - SWOT Analysis
SWOT Analysis - Overview
Evotec SE - Strengths
Evotec SE - Weaknesses
Evotec SE - Opportunities
Evotec SE - Threats
Evotec SE - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Evotec SE, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Evotec SE, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Evotec SE, Recent Deals Summary
Section 5 – Company’s Recent Developments
Aug 14, 2019: Evotec reports first half-year 2019 results and corporate updates
Aug 01, 2019: Evotec: New IMI project 'GNA Now' kicks off its Battle Against Antimicrobial Resistance
Jul 09, 2019: Evotec spin-off to develop cancer drugs using DDR pathway
Jul 08, 2019: Evotec and Venture Capital Consortium form 'Breakpoint Therapeutics'
Jul 05, 2019: Nosopharm and Evotec to develop antibiotic drugs
Jun 26, 2019: LineaRx Ships DNA to support therapy development for neurodegenerative diseases
Jun 24, 2019: Evotec, Sensyne Health, The University Of Oxford, OSI, and OUI create new bridge partnership 'LAB10X' in digital health
Jun 10, 2019: Evotec receives $ 23.8 m grant to join the global fight against tuberculosis
May 22, 2019: Evotec to acquire biologics company Just Biotherapeutics
May 19, 2019: Evotec and GARDP announce new partnership to discover novel antibiotics
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Evotec SE, Key Facts
Evotec SE, Key Employees
Evotec SE, Key Employee Biographies
Evotec SE, Major Products and Services
Evotec SE, History
Evotec SE, Subsidiaries
Evotec SE, Joint Venture
Evotec SE, Key Competitors
Evotec SE, Ratios based on current share price
Evotec SE, Annual Ratios
Evotec SE, Annual Ratios (Cont...1)
Evotec SE, Annual Ratios (Cont...2)
Evotec SE, Interim Ratios
Evotec SE, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Evotec SE, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Evotec SE, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Evotec SE, Performance Chart (2014 - 2018)
Evotec SE, Ratio Charts
Evotec SE, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Evotec SE, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report